Skip to main content
Figure 25 | SpringerPlus

Figure 25

From: Enhanced glycemic control, pancreas protective, antioxidant and hepatoprotective effects by umbelliferon-α-D-glucopyranosyl-(2I → 1II)-α-D-glucopyranoside in streptozotocin induced diabetic rats

Figure 25

Effect of UFD on kidney in different groups of rat: (A) Normal control: Normal control histopathology showed normal size of glomerulus (green arrow) (B) Diabetic control: Histopathology of diabetic control rat showed inflammatory cell in blood vessels (brown arrow) and deposition of fats (yellow arrow) (C) UFD I (10 mg/kg): Histopathology of tested drug showed inflammation in blood vessels (brown arrow) and fat deposition (yellow arrow) (D) UFD II (20 mg/kg): Histopathology of tested drug showed only fat deposition (yellow arrow) (E) UFD III (40 mg/kg): Histopathology of tested drug showed normal kidney histopathology like the glibenclamide group (F) Glibenclamide (10 mg/kg): Glibenclamide treated animal histopathology shown the normal kidney. The samples were obtained from the same liver anatomical regions. For each group, 6 rats were examined and 80 pictures were taken. The above picture for each group was chosen randomly from the 80 pictures in this group. Original magnification, 10 × .

Back to article page